Cornelius “Neal” Sailer, M.S.J.
Cornelius “Neal” Sailer is the global senior director of life cycle
management for Sanofi Genzyme, a global leader in pharmaceutical and
biotechnology development. Based in Cambridge Massachusetts, Mr. Sailer is
responsible for the global strategy and development of new indications for a
promising new biologic compound.
With 30 years of pharmaceutical industry experience working in a variety of
roles and therapeutic areas, Mr. Sailer has been the Sanofi board representative
for Anceta, LLC (now AMGA Analytics) since 2007.
In 2006, Mr. Sailer earned a Master of Science in jurisprudence (M.S.J.)
degree from the Seton Hall University School of Law with a concentration in
health law and intellectual property and his Bachelor of Arts in biology from
the University of Northern Colorado in 1984.